Filter posts

Podcast: Dr. Jeffrey Almond, Sanofi Pasteur, on the BioGENEius Challenge

BIOtechNOW’s Tracy Cooley talks to Dr. Almond, vice president of discovery and external R&D for Sanofi …

Scientific American Worldview 2011 Preview - Three pioneers share keys to success for building biote...

Three biotech luminaries who have succeeded against all odds share their experiences building a biotech …

Keys to success for building biotech in emerging markets

Three biotech luminaries who have succeeded against all odds share their experiences building a biotech …

ISO: Biotech Humanitarian

We are looking for biotech humanitarians for our annual Biotech Humanitarian Award. The award recognizes …

The booming H1N1 vaccine market

The vaccine market is booming – and biotech companies are just one of the beneficiaries.  …

Perspectives on today's IPO candidates

Some speculation is coming back into the sector but most movement in public markets is …

Panelists make it personal

Panelists in the “Making it Personal” session discussed the clinical utility, comparative effectiveness implications and …

The race against pandemic flu

Panelists at this morning’s Therapeutic Workshop, “Predicting a Frontrunner in the Race Against Pandemic Flu” …

Positive results for Logical Therapeutics’ LT-NS001 vs. Naproxen clinical study

Logical Therapeutics, Inc. announced positive results of a Phase I/II clinical trial evaluating the gastrointestinal …

Endocyte awarded patent for vitamin receptor binding drug delivery conjugates

Endocyte, Inc. has been awarded a patent from the United States Patent and Trademark Office …